Top

Strahlentherapie und Onkologie

Published in:

01-05-2013 | Literatur kommentiert

Frühe postoperative Strahlentherapie nach radikaler Prostatektomie bei „High-risk“-Prostatakarzinompatienten weiterhin Standard

Langzeitergebnisse der EORTC-Studie 22911

Authors: Dr. M. Ehmann, F. Wenz

Published in: Strahlentherapie und Onkologie | Issue 5/2013

Auszug

Bolla M, Poppel H van, Tombal B et al (2012) Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long term results of a randomised controlled trial (EORTC trial 22911). Lancet 380:2018–2027 …

Bolla M et al (2005) Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911). Lancet 366:572–578PubMedCrossRef

Siegmann A et al (2011) Dose escalation for patients with decreasing PSA during radiotherapy for elevated PSA after radical prostatectomy improves biochemical progression-free survival: results of a retrospective study. Strahlenther Onkol 187:467–472PubMedCrossRef

Ost P et al (2009) Adjuvant high-dose intensity-modulated radiotherapy after radical prostatectomy for prostate cancer: clinical results in 104 patients. Eur Urol 56:669–675PubMedCrossRef

Wiegel T et al (2009) Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02/AUO AP 09/95. J Clin Oncol 27:2924–2930PubMedCrossRef

Williams MB, Hernandez J, Thompson I (2005) Luteinizing hormone-releasing hormone agonist effects on skeletal muscle: how hormonal therapy in prostate cancer affects muscular strength. J Urol 173:1067–1071PubMedCrossRef

Stephenson AJ et al (2007) Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy. J Clin Oncol 25:2035–2041PubMedCrossRef

Radiotherapy – Adjuvant Versus Early Salvage (RAVES). ClinicalTrials.gov Identifier: NCT00860652

Parker C et al (2007) RADICALS (Radiotherapy and Androgen Deprivation in Combination after Local Surgery). Clin Oncol (R Coll Radiol) 19:67–171

10.

Triptorelin and radiation therapy in treating patients who have undergone surgery for intermediate-risk stage III or stage IV prostate cancer. ClinicalTrials.gov Identifier: NCT00667069

Title: Frühe postoperative Strahlentherapie nach radikaler Prostatektomie bei „High-risk“-Prostatakarzinompatienten weiterhin Standard
Langzeitergebnisse der EORTC-Studie 22911
Authors: Dr. M. Ehmann
F. Wenz
Publication date: 01-05-2013
Publisher: Springer-Verlag
Published in: Strahlentherapie und Onkologie / Issue 5/2013
Print ISSN: 0179-7158
Electronic ISSN: 1439-099X
DOI: https://doi.org/10.1007/s00066-013-0333-2

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Frühe postoperative Strahlentherapie nach radikaler Prostatektomie bei „High-risk“-Prostatakarzinompatienten weiterhin Standard

Langzeitergebnisse der EORTC-Studie 22911

Auszug

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Auszug

Please log in to get access to this content

Other articles of this Issue 5/2013

Validation of a survival score for patients treated with whole-brain radiotherapy for brain metastases

Quasi-VMAT in high-grade glioma radiation therapy

Comparison of four target volume definitions for pancreatic cancer

Lebensqualität nach Chirurgie oder Radiochirurgie von Hirnmetastasen und adjuvanter Ganzhirnbestrahlung

Erratum to: Is the simultaneously integrated boost (SIB) technique for early breast cancer ready to be adopted for routine adjuvant radiotherapy?

Lebermetastasen kolorektaler Karzinome ≤ 3 cm können sicher mit Radiofrequenzablation behandelt werden